SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001144204-10-029003
Filing Date
2010-05-19
Accepted
2010-05-19 14:18:56
Documents
3
Period of Report
2009-09-30

Document Format Files

Seq Description Document Type Size
1 v185720_10qa.htm 10-Q/A 331373
2 v185720_ex31-1.htm EX-31.1 8973
3 v185720_ex32-1.htm EX-32.1 16673
  Complete submission text file 0001144204-10-029003.txt   358743
Mailing Address 710 POST OAK SUITE 410 HOUSTON TX 77024
Business Address 710 POST OAK SUITE 410 HOUSTON TX 77024 713-780-0806
Oncolin Therapeutics, Inc. (Filer) CIK: 0001229089 (see all company filings)

IRS No.: 880507007 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-Q/A | Act: 34 | File No.: 000-50541 | Film No.: 10844867
SIC: 2834 Pharmaceutical Preparations